Empowered Patient Podcast: Discussing Fat Metabolism
Anti-Obesity Drug Targets the CB1 Receptor via the Endocannabinoid System
CEO Punit Dhillon discusses the potential to shift the weight-loss paradigm from primarily caloric restriction to more broadly address underlying issues related to fat metabolism.